Research Paper
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects
Nicholas J. Delva, Deborah L. Brooks, Michael Franklin, Khalid Al-Said, Emily R. Hawken, Zul Merali, J. Stuart Lawson and Arun V. Ravindran
J Psychiatry Neurosci November 01, 2002 27 (6) 429-437;
Nicholas J. Delva
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
MDDeborah L. Brooks
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
BA, MIRMichael Franklin
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
PhDKhalid Al-Said
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
MDEmily R. Hawken
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
BScZul Merali
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
PhDJ. Stuart Lawson
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
PhDArun V. Ravindran
Delva — Departments of Psychiatry and Physiology, Queen’s University, Providence Continuing Care Centre, Mental Health Services, Kingston, Department of Psychiatry, University of Ottawa and Royal Ottawa Hospital, Ottawa, Ont.; Brooks, Al-Said — Royal Ottawa Hospital, Ottawa, Ont.; Franklin — Oxford University Department of Psychiatry, Warneford Hospital, Oxford, England; Hawken — Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Merali — Departments of Psychology and Pharmacology, University of Ottawa, Ottawa, Ont.; Lawson — Department of Psychiatry, Queen’s University, and Providence Continuing Care Centre, Mental Health Services, Kingston, Ont.; Ravindran — Royal Ottawa Hospital and Department of Psychiatry, University of Ottawa, Ottawa, Ont.
MB BS, PhD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
J Psychiatry Neurosci
Vol. 27, Issue 6
1 Nov 2002
Article tools
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects
Nicholas J. Delva, Deborah L. Brooks, Michael Franklin, Khalid Al-Said, Emily R. Hawken, Zul Merali, J. Stuart Lawson, Arun V. Ravindran
J Psychiatry Neurosci Nov 2002, 27 (6) 429-437;
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects
Nicholas J. Delva, Deborah L. Brooks, Michael Franklin, Khalid Al-Said, Emily R. Hawken, Zul Merali, J. Stuart Lawson, Arun V. Ravindran
J Psychiatry Neurosci Nov 2002, 27 (6) 429-437;
Related Articles
- No related articles found.
Cited By...
- No citing articles found.